Nawar Latif, MD, MPH, MSCE
Gynecologic Oncology
Accepting new patients
Sees patients age 15 and up
Penn Gynecologic Oncology Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Surgical Director of the living donor uterus transplant program at Penn
  • Co-Principle investigator of the Uterus Transplant trial
  • Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Latif specializes in gynecologic oncology. He serves as an assistant professor of obstetrics and gynecology and as a co-priniciple investigator of the Uterus Transplant for Uterine Factor Infertility (UNTIL) Trial.

Education and training

  • Medical School: University of Baghdad
  • Residency: Northwestern Memorial Hospital
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

447 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

December 2025
he explained my concerns
November 2025
answers questions well
November 2025
i feel like he is technically skilled at helping patients get the most positive outcomes.
November 2025
she was excellent!!!

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Latif is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. , Int J Gynecol Cancer, 35(6):101897: 2025

Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. , Int J Gynecol Cancer, 35(6):101748: 2025

Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. , Int J Gynecol Cancer, 35(5):101798: 2025

Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. , Cancers (Basel), 16(11):2051: 2025

Labban N, Li S, Ahmed M, Nandish N, Torigian D, Udupa J, Tong Y, Gysler S, Latif N Optimal biomarkers derived from preoperative CT scans to predict postoperative morbidity in patients with ovarian cancer. Poster presentation, , The Society of Gynecologic Oncology Annual Meeting: 2025

Nasioudis D, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes. , Int J Gynecol Cancer, 34(12):1874-1880: 2024

Andriani L, Aggarwal A, Bailey N, Seltzer E, Oliver S, Mills L, DeAgostino-Kelly M, Haggerty A, Latif N Together Care: Transforming Perioperative Care for Patients Undergoing Benign and Oncologic Gynecologic Surgery. , NEJM Catal Innov Care Deliv , 5(12): 2024

Labban N, Li S, Ahmed M, Nandish N, Torigian D, Udupa J, Tong Y, Gysler S, Latif N Optimal biomarkers derived from preoperative CT scans to predict postoperative morbidity in patients with ovarian cancer. , Oral presentation. Mid-Atlantic Gynecologic Oncology Society Conference. Atlanta, GA: 2024

Nasioudis D, Labban N, Latif N, Gysler S, Cory L, Kim S, Giuntoli RL 2nd, Ko EM Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes. , Int J Gynecol Cancer, 33(9):1347-1353: 2024

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. , Int J Gynecol Cancer, 34(7):969-974: 2024